tradingkey.logo

Rapid Micro Biosystems Inc

RPID
3.215USD
+0.065+2.06%
Market hours ETQuotes delayed by 15 min
142.45MMarket Cap
LossP/E TTM

Rapid Micro Biosystems Inc

3.215
+0.065+2.06%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Rapid Micro Biosystems Inc

Currency: USD Updated: 2025-12-19

Key Insights

Rapid Micro Biosystems Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 117/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 8.00.In the medium term, the stock price is expected to remain stable.Despite a very weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Rapid Micro Biosystems Inc's Score

Industry at a Glance

Industry Ranking
117 / 208
Overall Ranking
278 / 4582
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
8.000
Target Price
+101.01%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Rapid Micro Biosystems Inc Highlights

StrengthsRisks
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 63.72% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 28.05M.
Undervalued
The company’s latest PE is -3.16, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 23.72M shares, decreasing 6.05% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 965.02K shares of this stock.

Financial Health

Currency: USD Updated: 2025-12-19

The current financial score of Rapid Micro Biosystems Inc is 5.85, ranking 187/208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 7.84M, representing a year-over-year increase of 3.08%, while its net profit experienced a year-over-year increase of 1.61%.

Score

Industry at a Glance

Previous score
5.85
Change
0

Financials

7.20

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.24

Operational Efficiency

2.88

Growth Potential

4.87

Shareholder Returns

7.07

Rapid Micro Biosystems Inc's Company Valuation

Currency: USD Updated: 2025-12-19

The current valuation score of Rapid Micro Biosystems Inc is 6.09, ranking 177/208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -3.16, which is -83.61% below the recent high of -0.52 and -41.67% above the recent low of -4.47.

Score

Industry at a Glance

Previous score
6.09
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 117/208
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-19

The current earnings forecast score of Rapid Micro Biosystems Inc is 8.50, ranking 30/208 in the Healthcare Equipment & Supplies industry. The average price target for Rapid Micro Biosystems Inc is 8.00, with a high of 8.00 and a low of 8.00.

Score

Industry at a Glance

Previous score
8.50
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
8.000
Target Price
+101.01%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

90
Total
4
Median
7
Average
Company name
Ratings
Analysts
Rapid Micro Biosystems Inc
RPID
4
Boston Scientific Corp
BSX
36
Intuitive Surgical Inc
ISRG
34
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
34
Thermo Fisher Scientific Inc
TMO
27
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-19

The current price momentum score of Rapid Micro Biosystems Inc is 6.50, ranking 142/208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 3.91 and the support level at 2.77, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.65
Change
-0.15

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.235
Neutral
RSI(14)
32.031
Neutral
STOCH(KDJ)(9,3,3)
5.718
Oversold
ATR(14)
0.255
High Vlolatility
CCI(14)
-130.033
Sell
Williams %R
100.000
Oversold
TRIX(12,20)
-0.236
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
3.364
Sell
MA10
3.600
Sell
MA20
3.849
Sell
MA50
3.524
Sell
MA100
3.283
Sell
MA200
3.129
Buy

Institutional Confidence

Currency: USD Updated: 2025-12-19

The current institutional shareholding score of Rapid Micro Biosystems Inc is 5.00, ranking 111/208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 59.74%, representing a quarter-over-quarter decrease of 16.21%. The largest institutional shareholder is The Vanguard, holding a total of 965.02K shares, representing 2.42% of shares outstanding, with 5.44% increase in holdings.

Score

Industry at a Glance

Previous score
5.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Bain Capital Life Sciences Investors, LLC
8.43M
--
Kennedy Lewis Investment Management LLC
4.94M
--
Longitude Capital Management Co., LLC
3.56M
--
Endeavour Medtech Growth II LP
2.26M
--
Ally Bridge Group (HK) Limited
1.85M
--
The Vanguard Group, Inc.
Star Investors
904.36K
+1.58%
Parkman Healthcare Partners LLC
913.44K
+24.17%
Schonfeld Strategic Advisors LLC
1.04M
+0.86%
Advent International L.P.
577.78K
--
Spignesi (Robert G JR)
493.93K
-43.38%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-19

The current risk assessment score of Rapid Micro Biosystems Inc is 2.25, ranking 167/208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.39. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.25
Change
0
Beta vs S&P 500 index
1.37
VaR
--
240-Day Maximum Drawdown
+49.23%
240-Day Volatility
+123.55%

Return

Best Daily Return
60 days
+16.05%
120 days
+16.05%
5 years
--
Worst Daily Return
60 days
-10.58%
120 days
-17.79%
5 years
--
Sharpe Ratio
60 days
+0.38
120 days
+0.19
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+49.23%
3 years
+58.13%
5 years
--
Return-to-Drawdown Ratio
240 days
+4.18
3 years
+0.81
5 years
--
Skewness
240 days
+1.08
3 years
+1.17
5 years
--

Volatility

Realised Volatility
240 days
+123.55%
5 years
--
Standardised True Range
240 days
+9.17%
5 years
--
Downside Risk-Adjusted Return
120 days
+29.71%
240 days
+29.71%
Maximum Daily Upside Volatility
60 days
+60.69%
Maximum Daily Downside Volatility
60 days
+61.22%

Liquidity

Average Turnover Rate
60 days
+0.21%
120 days
+0.31%
5 years
--
Turnover Deviation
20 days
-38.37%
60 days
-40.59%
120 days
-12.93%

Peer Comparison

Healthcare Equipment & Supplies
Rapid Micro Biosystems Inc
Rapid Micro Biosystems Inc
RPID
6.10 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
Tactile Systems Technology Inc
TCMD
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Rapid Micro Biosystems Inc?

The TradingKey Stock Score provides a comprehensive assessment of Rapid Micro Biosystems Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Rapid Micro Biosystems Inc’s performance and outlook.

How do we generate the financial health score of Rapid Micro Biosystems Inc?

To generate the financial health score of Rapid Micro Biosystems Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Rapid Micro Biosystems Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Rapid Micro Biosystems Inc.

How do we generate the company valuation score of Rapid Micro Biosystems Inc?

To generate the company valuation score of Rapid Micro Biosystems Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Rapid Micro Biosystems Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Rapid Micro Biosystems Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Rapid Micro Biosystems Inc.

How do we generate the earnings forecast score of Rapid Micro Biosystems Inc?

To calculate the earnings forecast score of Rapid Micro Biosystems Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Rapid Micro Biosystems Inc’s future.

How do we generate the price momentum score of Rapid Micro Biosystems Inc?

When generating the price momentum score for Rapid Micro Biosystems Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Rapid Micro Biosystems Inc’s prices. A higher score indicates a more stable short-term price trend for Rapid Micro Biosystems Inc.

How do we generate the institutional confidence score of Rapid Micro Biosystems Inc?

To generate the institutional confidence score of Rapid Micro Biosystems Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Rapid Micro Biosystems Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Rapid Micro Biosystems Inc.

How do we generate the risk management score of Rapid Micro Biosystems Inc?

To assess the risk management score of Rapid Micro Biosystems Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Rapid Micro Biosystems Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Rapid Micro Biosystems Inc.
KeyAI